TrialJAMA network open2025

Azetukalner, a Novel KV7 Potassium Channel Opener, in Adults With Major Depressive Disorder: A Randomized Clinical Trial.

Noam N Butterfield et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.